Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 9,138 | 9,181 | 12,256 | 9,191 | 8,164 |
| Cost of Goods | 3,219 | 3,115 | 3,593 | 2,586 | 1,836 |
| Gross Profit | 5,919 | 6,066 | 8,663 | 6,605 | 6,328 |
| Operating Expenses | 31,319 | 33,160 | 31,000 | 37,351 | 33,373 |
| Operating Income | -25,181 | -26,979 | -21,744 | -30,160 | -26,209 |
| Interest Expense | 1,683 | 1,754 | 1,696 | 1,710 | 1,723 |
| Other Income | 446 | 1,926 | -855 | -191 | 17,260 |
| Pre-tax Income | -26,418 | -26,807 | -24,295 | -32,061 | -10,672 |
| Net Income Continuous | -26,418 | -26,807 | -24,295 | -32,061 | -10,672 |
| Net Income | $-26,418 | $-26,807 | $-24,295 | $-32,061 | $-10,672 |
| EPS Basic Total Ops | -1.10 | -1.10 | -1.00 | -1.40 | -0.50 |
| EPS Basic Continuous Ops | -1.09 | -1.11 | -1.03 | -1.46 | -0.49 |
| EPS Diluted Total Ops | -1.10 | -1.10 | -1.00 | -1.40 | -0.50 |
| EPS Diluted Continuous Ops | -1.09 | -1.11 | -1.03 | -1.45 | -0.49 |
| EBITDA(a) | $-22,638 | $-24,358 | $-19,258 | $-27,793 | $-23,837 |